Stock Market Reviews

Stock Ticker News

Get the latest news, insights, and market updates on all tickers. Explore the news page 19 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Incyte Corp. (INCY) Reports Q4 2025 Revenue Growth of 28% to $1.51B Driven by Jakafi and Opzelura Sales
  Incyte Corporation (NASDAQ:INCY) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 10, Incyte Corporation reported that the company’s Q4 2025 revenue climbed 28% to $1.51 billion, while full-year sales reached $5.14 billion. The company’s growth was largely propelled by its flagship product, Jakafi, which achieved annual […]
  Feb 20, 2026 - $INCY
• indie Semiconductor Q4 Earnings Call Highlights
  indie Semiconductor (NASDAQ:INDI) reported fourth-quarter 2025 revenue of $58 million, topping the midpoint of its outlook by $1 million and rising 8% sequentially, as management highlighted continued momentum in advanced driver-assistance systems (ADAS) programs and early contributions from newer a
  Feb 20, 2026 - $INDI
• Gold prices rise as investors eye US-Iran tensions
  Gold prices rose on Friday morning, as tensions between the US and Iran fuelled demand for safe haven assets.
  Feb 20, 2026 - $ING
• Inseego Q4 Earnings Call Highlights
  Inseego (NASDAQ:INSG) reported fourth-quarter 2025 results that topped its guidance, with management emphasizing sequential improvement in both revenue and profitability and pointing to an expanded Tier 1 carrier footprint as a key driver heading into 2026. Fourth-quarter results exceed guidance CE
  Feb 20, 2026 - $INSG
• Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy
  Insmed Inc. (NASDAQ:INSM) ranks among billionaire Stanley Druckenmiller’s 10 best stock picks. On January 23, Roth/MKM began coverage of Insmed Inc. (NASDAQ:INSM) with a Buy rating and a $212 price target. The firm pointed to Insmed’s solid position for further upside in 2026, with predictions that the company’s Brinsupri medication will continue to exceed market […]
  Feb 20, 2026 - $INSM
• Nvidia (NVDA) Partners With Meta Platforms in Multiyear Deal for Millions of Blackwell and Rubin AI Chips
  Nvidia Corporation (NASDAQ:NVDA) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 18, Nvidia announced a multiyear agreement to supply Meta Platforms with millions of artificial intelligence chips and central processing units. This deal includes the current Blackwell architecture alongside the forthcoming Rubin AI chips. Notably, the […]
  Feb 20, 2026 - $INTC
• Back Near $1,000, Is Costco Stock a Buy Now?
  Costco's sales continue to look strong, but is the stock priced for perfection?
  Feb 20, 2026 - $INTC
• Is Coca-Cola Still the Ultimate Dividend Stock to Buy Now and Hold Forever?
  The beverage giant can provide decades of passive income.
  Feb 20, 2026 - $INTC
• If You'd Invested $100 in Palo Alto Networks (PANW) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Have More Than Doubled Your Dollars)
  The need for cybersecurity is not going away anytime soon -- which is great for this company.
  Feb 20, 2026 - $INTC
• Why Vertex Stock Zoomed Almost 6% Higher on Thursday
  The company has several juicy growth opportunities ahead of it, a market professional tracking its fortunes believes.
  Feb 20, 2026 - $INTC